NCT05987436

Brief Summary

The goal of this observational study is to evaluate the effects of a supervised aerobic exercise training program on weight loss, functional capacity, quality of life (QoL), and depression levels in patients with essential hypertension.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
138

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

July 25, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
Last Updated

August 14, 2023

Status Verified

August 1, 2023

Enrollment Period

1.4 years

First QC Date

July 25, 2023

Last Update Submit

August 3, 2023

Conditions

Keywords

supervised aerobic exercisefunctional capacityquality of lifedepression levelessential hypertension

Outcome Measures

Primary Outcomes (5)

  • Body weight

    kilograms

    was measured at the pre-treatment period and the post-treatment 6th week for all the participants by the same physician.

  • Blood samples

    Serum total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, very-low-density lipoprotein (VLDL) cholesterol, and triglycerides

    Twelve-hour fasting blood samples were collected between 6.00 am, and 10.00 am at baseline and week 6.

  • The functional capacity

    The 6MWT test and the estimated metabolic equivalents or METs were used performed to evaluate functional capacity.

    6MWT was assessed in face-to-face interviews before and immediately after the treatment was completed.

  • Quality of Life

    Quality of life was assessed with Short Form-36 (SF-36).

    SF36 was assessed in face-to-face interviews before and immediately after the treatment was completed.

  • Depression level

    Depression level was assessed Beck Depression Inventory (BDI).

    BDI was assessed in face-to-face interviews before and immediately after the treatment was completed.

Study Arms (2)

Group 1

Group 1 exercised for six weeks, involving once per day, five sessions per week under the supervision of a medical doctor, and a nurse in the aerobic exercise laboratory. The aerobic exercise training program lasted six weeks, and patients lived in the hospital for the whole period. Aerobic exercise training was performed on cycle ergometers (Ergoline, ergoselect II 100/200/Reha, Germany) equipped with a computed ergometer and developed to monitor electrocardiography (ECG), heart rhythm, and BP. Each session consisted of a 5-minute warm-up, followed by 50 minutes of aerobic exercise with an intensity of 50% to 70% of heart rate reserve, calculated by Karvonen formula, and ended with a 5-min cool-down period.

Other: Supervised Aerobic Exercise

Group 2

The subjects assigned to the control group (Group 2) were advised to maintain dietary habits and physical activity levels and the aerobic exercise program was provided to them after completing the study.

Interventions

Group 1 exercised for six weeks, five sessions per week under the supervision of a medical doctor in the aerobic exercise laboratory.

Group 1

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Essential Hypertension

You may qualify if:

  • Over 18 years of age,
  • Absence of concomitant other metabolic and cardiovascular diseases.

You may not qualify if:

  • Having suffered an event of ischaemic heart disease (\<6 months),
  • Secondary hypertension,
  • Hypertrophic obstructive cardiomyopathy,
  • Congestive heart failure,
  • Uncontrolled cardiac arrhythmia,
  • Thyroid dysfunction,
  • Diabetes mellitus,
  • Symptomatic peripheral arterial occlusive disease,
  • Aortic insufficiency or stenosis,
  • Pulmonary or heart disease with dyspnoea at small or moderate effort,
  • An outbreak of orthopedic problems on hip, knee or ankles, such as arthroplasty, contracture or severe osteoarthritis,
  • Using of antidepressant or anxiolytic drugs,
  • Pregnancy,
  • Cognitive disfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Selcuk University Faculty of Medicine

Konya, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Essential Hypertension

Condition Hierarchy (Ancestors)

HypertensionVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

July 25, 2023

First Posted

August 14, 2023

Study Start

November 1, 2017

Primary Completion

April 1, 2019

Study Completion

December 1, 2019

Last Updated

August 14, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations